TARO-LENALIDOMIDE

Identification of Taro-Lenalidomide

No description

Google image searchProduct monograph

Active ingredient

lenalidomide, 2.5 MG

DIN: 02507862

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Prescription

Company: TARO PHARMACEUTICALS INC

Date: 13-JUN-2022

ATC:

Reference brand drug: Revlimid

Pharmaceutical standard: MFR

Search on Google

Taro Pharmaceuticals Inc

Go to Taro website to see drug product details. Sometimes you can find taro-lenalidomide photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.